MS: Busting the Myths
December 20, 2023 | Advocacy, Life with MS, Treatments
On the 1st of October Ocrevus (Ocrelizumab) was finally funded for those with Primary Progressive MS (PPMS) who meet the Pharmac criteria for access. We prepared some information to answer the most common questions we have been receiving. Ocrevus for […]
December 5, 2023 | Carer, Carers, Event, Life with MS, MS Voice, Newsletter, Petition, Support, Treatments, Webinar
Welcome to our November 2023 edition of MS Voice. This month we introduce you to our new banger, invite you to our bladder and bowel health webinar and provide you with up-to-date research and development, amongst other exciting updates. View […]
November 28, 2023 | Research, Study, Treatments, Trials
MSNZ note this was a small trial and it’s in the very early stages but this is an interesting development in stem cell research. Doctors are cautiously hopeful about a new multiple sclerosis therapy after finding that injecting stem cells […]
November 14, 2023 | Education, Media, Research, Training, Treatments
In this report, Dr John Mottershead provides an overview of the recent MSMilan 2023 Conference he attended. In this review: – NGDs which mimic MS – Junior resident accuracy in recognising MS – Alternative diagnoses in suspected MS – Tapering of oral prednisone after […]
September 19, 2023 | Treatments
Mavenclad® Cladribine – Have your Say MSNZ is currently preparing a submission to Pharmac to urge them to again consider funding Mavenclad (Cladribine) for Relapsing Remitting MS. Our submission is due this Friday 22nd September. Real world and clinical trial […]